A Phase II Open-Label, Two Arm Trial To Evaluate The Eff

A Phase Ii Open-Label, Two Arm Trial To Evaluate The Eff

Sponsor(s)

Pfizer

Principal Investigator(s)Fadlo R Khuri, MD, FACP
Dates9/03/2008 - 1/31/2012